Cargando…
Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation
The occurrence of SOX2-specific autoantibodies seems to be associated with an improved prognosis in patients with monoclonal gammopathy of undetermined significance (MGUS). However, it is unclear if SOX2-specific antibodies also develop in established multiple myeloma (MM). Screening 1094 peripheral...
Autores principales: | Kobold, Sebastian, Tams, Sinje, Luetkens, Tim, Cao, Yanran, Sezer, Orhan, Bartels, Britta Marlen, Reinhard, Henrike, Templin, Julia, Bartels, Katrin, Hildebrandt, York, Lajmi, Nesrine, Marx, Andreas, Haag, Friedrich, Bokemeyer, Carsten, Kröger, Nicolaus, Atanackovic, Djordje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227434/ https://www.ncbi.nlm.nih.gov/pubmed/22190969 http://dx.doi.org/10.1155/2011/302145 |
Ejemplares similares
-
Longitudinal Analysis of Tetanus- and Influenza-Specific
IgG Antibodies in Myeloma Patients
por: Kobold, Sebastian, et al.
Publicado: (2012) -
Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
por: Yousef, Sara, et al.
Publicado: (2015) -
Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies
por: Kobold, Sebastian, et al.
Publicado: (2010) -
5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity
por: Stübig, Thomas, et al.
Publicado: (2014) -
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
por: Panse, J, et al.
Publicado: (2008)